betaxolol and eye
betaxolol has been researched along with eye in 20 studies
Research
Studies (20)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 7 (35.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Kitada, S; Lee, DA; Nguyen, KD; Shapourifar-Tehrani, S; Williams, DE | 1 |
| Hesse, R; Kendall, K; Lavin, P; Mundorf, T; Nardin, G; Zimmerman, TJ | 1 |
| Bosem, ME; Lusky, M; Morsman, CD; Weinreb, RN | 1 |
| Kompella, UB; Lee, VH; Lee, YH | 1 |
| Hong, SJ; Wang, HZ; Wu, KY | 1 |
| Carvalho, AL; Cazevieille, C; DeSantis, L; Larsen, AK; Osborne, NN | 1 |
| Barros, MD; Bodor, N; Farag, HH; Prokai, L; Somogyi, G; Wu, WM | 1 |
| Cantor, LB; Evans, DW; Harris, A | 1 |
| Crider, JY; Davis, TL; McLaughlin, M; Sharif, NA; Xu, SX | 1 |
| Ishibashi, Y; Muto, T; Roy, S; Sato, T | 1 |
| Bunce, C; Garway-Heath, DF; Hitchings, RA; Indar, A; Poinoosawmy, D | 1 |
| Araie, M; Fukaya, Y; Ishii, K; Matsuo, H; Sakaki, H; Tanaka, S; Waki, M | 1 |
| Asagidag, A; Celik, A; Ermis, SS; Inan, UU; Onrat, E; Orman, A; Ozturk, F; Yucel, A | 1 |
| Holló, G | 1 |
| Argikar, UA; Bushee, JL; Dunne, CE | 1 |
| Fu, L; Hua, H; Huang, W; Liu, T; Ma, X; Tang, Y; Yang, Y; Zhang, N; Zhao, Y | 1 |
| Chen, Y; Gui, R; Hou, D; Hu, S; Huang, Y; Tao, Q; Tian, S; Wang, Y; Yang, L | 1 |
| Cheng, H; Huo, Y; Mao, S; Zhu, Q | 1 |
| Guan, J; Li, C; Mao, S; Wei, Y; Zhang, X; Zhu, Q | 1 |
| Dai, F; Hou, D; Hu, J; Li, H; Li, W; Lin, H; Liu, H; Rupenthal, ID; Tao, Q; Xiao, Z; Yang, F; Zhang, Y | 1 |
Trials
3 trial(s) available for betaxolol and eye
| Article | Year |
|---|---|
The effect of topical beta-adrenoceptor blocking agents on pulsatile ocular blood flow.
Topics: Adrenergic beta-Antagonists; Betaxolol; Eye; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Levobunolol; Male; Middle Aged; Ocular Hypertension; Pulsatile Flow; Time Factors; Timolol | 1995 |
Primary open-angle glaucoma patients characterized by ocular vasospasm demonstrate a different ocular vascular response to timolol versus betaxolol.
Topics: Adrenergic beta-Antagonists; Betaxolol; Cross-Over Studies; Double-Blind Method; Eye; Female; Glaucoma, Open-Angle; Hemodynamics; Humans; Hypercapnia; Intraocular Pressure; Male; Middle Aged; Ophthalmic Artery; Spasm; Timolol; Ultrasonography, Doppler, Color; Vascular Resistance | 1999 |
The comparative cardiovascular, pulmonary, ocular blood flow, and ocular hypotensive effects of topical travoprost, bimatoprost, brimonidine, and betaxolol.
Topics: Administration, Topical; Adult; Amides; Betaxolol; Bimatoprost; Brimonidine Tartrate; Cardiovascular System; Cloprostenol; Cross-Over Studies; Double-Blind Method; Eye; Humans; Intraocular Pressure; Lipids; Male; Ocular Hypotension; Prospective Studies; Pulmonary Circulation; Quinoxalines; Regional Blood Flow; Travoprost | 2004 |
Other Studies
17 other study(ies) available for betaxolol and eye
| Article | Year |
|---|---|
Effects of timolol, betaxolol, and levobunolol on human tenon's fibroblasts in tissue culture.
Topics: Benzalkonium Compounds; Betaxolol; Cell Adhesion; Cell Division; Cells, Cultured; DNA Replication; Eye; Fascia; Fibroblasts; Humans; Levobunolol; Timolol | 1992 |
Tolerability of timolol and betaxolol in patients with chronic open-angle glaucoma.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Betaxolol; Chronic Disease; Drug Tolerance; Eye; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Ophthalmic Solutions; Propanolamines; Timolol | 1987 |
Systemic absorption pathways of topically applied beta adrenergic antagonists in the pigmented rabbit.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Biological Availability; Conjunctiva; Eye; Levobunolol; Male; Nasal Mucosa; Nasolacrimal Duct; Rabbits; Time Factors; Timolol | 1993 |
Effects of pilocarpine and other antiglaucoma drugs on cultured human Tenon's fibroblast cells.
Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Cell Division; Cells, Cultured; Eye; Fibroblasts; Glaucoma; Humans; Levobunolol; Muscarinic Agonists; Pilocarpine; Thymidine; Timolol | 1997 |
In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent.
Topics: Animals; Betaxolol; Calbindin 2; Calcium; Cell Hypoxia; Cells, Cultured; Chick Embryo; Choline O-Acetyltransferase; Electroretinography; Eye; Eye Proteins; Glutamic Acid; L-Lactate Dehydrogenase; Neurons; Neuroprotective Agents; Neurotoxins; Oxygen; Rabbits; Rats; Rats, Inbred Strains; Reperfusion Injury; Retinal Ganglion Cells; S100 Calcium Binding Protein G; Sympatholytics | 1997 |
Ocular-specific chemical delivery systems of betaxolol for safe local treatment of glaucoma.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Eye; Glaucoma; Intraocular Pressure; Male; Prodrugs; Rabbits; Rats; Rats, Sprague-Dawley; Stereoisomerism; Tachycardia | 1997 |
Levobetaxolol (Betaxon): in vitro pharmacology, intraocular pressure lowering activity and autoradiographic localization of beta-adrenoceptors in human eyes.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Autoradiography; Betaxolol; Binding, Competitive; Epinephrine; Eye; Guinea Pigs; Humans; In Vitro Techniques; Intraocular Pressure; Isoproterenol; Macaca fascicularis; Rats; Receptors, Adrenergic, beta | 2001 |
Short-term effect of beta-adrenoreceptor blocking agents on ocular blood flow.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Blood Flow Velocity; Blood Pressure; Carteolol; Choroid; Ciliary Body; Eye; Heart Rate; Intraocular Pressure; Rabbits; Random Allocation; Regional Blood Flow; Retinal Vessels; Timolol; Vascular Resistance | 2001 |
Effect of treatment by medicine or surgery on intraocular pressure and pulsatile ocular blood flow in normal-pressure glaucoma.
Topics: Administration, Topical; Aged; Antihypertensive Agents; Betaxolol; Blood Flow Velocity; Brimonidine Tartrate; Eye; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Ophthalmic Solutions; Prostaglandins F, Synthetic; Pulsatile Flow; Quinoxalines; Retrospective Studies; Tonometry, Ocular; Trabeculectomy | 2002 |
Iganidipine, a new water-soluble Ca2+ antagonist: ocular and periocular penetration after instillation.
Topics: Administration, Topical; Animals; Anterior Eye Segment; Autoradiography; Betaxolol; Calcium; Calcium Channel Blockers; Calcium Channels; Endothelin-1; Eye; Injections, Intravenous; Ophthalmic Solutions; Piperazines; Pyridines; Rabbits; Retina; Retinal Artery; Solubility; Vasoconstriction; Vasodilator Agents | 2003 |
Pharmacological neuroprotection for glaucoma.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Eye; Glaucoma; Humans; Neuroprotective Agents | 2007 |
An in vitro approach to investigate ocular metabolism of a topical, selective β1-adrenergic blocking agent, betaxolol.
Topics: Administration, Topical; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Animals; Betaxolol; Chromatography, Liquid; Eye; Female; Humans; Male; Metabolomics; Middle Aged; Rabbits; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Young Adult | 2015 |
Preparation, pharmacokinetics and pharmacodynamics of ophthalmic thermosensitive in situ hydrogel of betaxolol hydrochloride.
Topics: Animals; Betaxolol; Drug Liberation; Eye; Hydrogel, Polyethylene Glycol Dimethacrylate; Intraocular Pressure; Kinetics; Ophthalmic Solutions; Rabbits; Rheology; Temperature | 2016 |
A novel ion-exchange carrier based upon liposome-encapsulated montmorillonite for ophthalmic delivery of betaxolol hydrochloride.
Topics: Animals; Bentonite; Betaxolol; Calorimetry, Differential Scanning; Cell Survival; Cornea; Dialysis; Drug Delivery Systems; Drug Liberation; Eye; Frozen Sections; Humans; Intraocular Pressure; Ion Exchange; Liposomes; Nanocomposites; Particle Size; Rabbits; Solutions; Spectroscopy, Fourier Transform Infrared; Thermogravimetry; Time Factors; X-Ray Diffraction | 2017 |
Sustained ophthalmic delivery of highly soluble drug using pH-triggered inner layer-embedded contact lens.
Topics: Administration, Ophthalmic; Adrenergic beta-1 Receptor Antagonists; Animals; Betaxolol; Cellulose; Contact Lenses; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Eye; Hydrogen-Ion Concentration; Male; Polymethacrylic Acids; Rabbits; Solubility | 2018 |
Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution.
Topics: Animals; Betaxolol; Biological Availability; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Excipients; Eye; Gels; Methylcellulose; Ophthalmic Solutions; Poloxamer; Rabbits; Resins, Plant; Temperature; Tissue Distribution | 2020 |
Physicochemical properties and micro-interaction between micro-nanoparticles and anterior corneal multilayer biological interface film for improving drug delivery efficacy: the transformation of tear film turnover mode.
Topics: Bentonite; Betaxolol; Drug Delivery Systems; Drug Liberation; Eye | 2023 |